Last Friday (9th), Chinese Foreign Ministry spokesperson Hua Chunying announced that China has formally joined the “COVAX”. On the 11th local time, European Commission President Von der Lein welcomed China’s decision.
Von Delane wrote on Twitter that welcome China to join the COVAX. Von der Lein emphasized that the EU and China have the same goals, “Multilateralism is key to reaching our #GlobalGoal of access to vaccines everywhere” and “We look forward to working with China and other partners on this.”
I welcome China’s willingness to join #COVAX.
We are all in this together. Multilateralism is key to reaching our #GlobalGoal of access to vaccines everywhere, for everyone who needs them.
We look forward to working with China and other partners on this.
— Ursula von der Leyen (@vonderleyen) October 11, 2020
On the same day, Josep Borrell, the EU’s High Representative for Foreign and Security Policy, also expressed his appreciation for China’s decision. Borelli expressed his welcome to China’s participation in the plan. He said that “Only a truly global effort and commitment can win the fight against the pandemic.” and “Now it is about action and delivery.”
Only a truly global effort and commitment can win the fight against the pandemic.
— Josep Borrell Fontelles (@JosepBorrellF) October 11, 2020
The “COVAX” was created by the Global Alliance for Vaccines and Immunization (Gavi), the World Health Organization (WHO), and the Alliance for Epidemic Prevention Innovation (CEPI). The purpose is to improve the efficiency of vaccine development and to lay the foundation for the rapid production and mass and fair popularization of vaccines. The plan is to provide at least 2 billion doses of safe and effective Covid-19 vaccine globally by the end of 2021.
Chinese Foreign Ministry spokesperson Hua Chunying emphasized at a press conference on the 9th that although China’s multi-vessel vaccine research and development is at the international leading level and has sufficient production capacity, we have decided to join the “implementation plan.” The purpose is to promote the fair distribution of vaccines with practical actions and ensure that vaccines are provided to developing countries. At the same time, more capable countries will be encouraged to join and support the “implementation plan.”
Currently, more than 170 countries and economies around the world have joined this plan. China’s decision to join the plan has won widespread praise from the outside world. Seth Berkley, CEO of the Global Alliance for Vaccines and Immunization, once said that China’s decision to join the program can provide “more motivation” for countries to equitably obtain vaccines.
In addition, many foreign media have noticed the absence of the United States in this plan. Previously, the United States had refused to join on the grounds of not participating in any WHO-related activities. Such a comparison also made Bloomberg lament: China’s entry has filled the vacancy in global public health leadership after the United States rejected this plan.
Germany starts ordering 2022 vaccines, local leaders suggest approval of Chinese vaccines
German Health Minister Jens Spahn revealed on Saturday (30th) that the country has now begun to order the 2022 vaccine, because the spread of the variant new coronavirus may require an increase in the dose in the future.
According to Reuters news on the 31st, Spann said in a video conference for medical staff on the 30th that Germany is currently ordering 2022 vaccines, and at least some of them must be obtained first because no one knows whether there is a need to increase the number of vaccine injections in the future, or In order to maintain immunity to the new coronavirus, vaccines must be purchased in advance as a preventive measure. Spann said that 2.3 million people out of the 83 million German population have received the first dose of vaccine, but because vaccine manufacturers such as AstraZeneca, Pfizer, Modena, and other vaccine manufacturers suddenly announced reductions in production, European governments faced a shortage of vaccines. Both are quite a headache. The German government has set up a new vaccination task force, and it is also expected to convene federal and local government representatives, pharmaceutical companies, and EU representatives for a vaccine meeting on the 1st.
Germany, as the largest economy in Europe, stalled during the second blockade in November. Many Germans envied the faster vaccination rates in Britain, Israel, and other countries. The German federal government has continuously received criticisms of too slow vaccination progress. German media described the government vaccine program as a “scandal.” Public opinion surveys show that people’s satisfaction with the government’s epidemic prevention has dropped to 49%, the lowest point since the epidemic.
Before the meeting of the new vaccination working group, some powerful regional leaders in Germany also expressed dissatisfaction with the federal epidemic prevention and control measures. The governor of Bavaria, Markus Soeder, put forward a new proposal that requires the federal state to allow the state to have more say in the supply of vaccines to the groups most in need. Soder said, “We need an emergency vaccine economy system, and the country must formulate clear rules,” he called on the authorities to consider approving Chinese and Russian vaccines for use in other European countries.
According to reports, as of the 30th, Germany had 13,321 new cases and 794 deaths in a single day, with a total of more than 2.21 million confirmed cases and 56,000 deaths. Although the number of cases per 100,000 people has dropped by 3 in the past 7 days to 91 cases. The government stated that the number must be less than 50 cases to prevent hospitals from being overwhelmed. In addition, the German Ministry of the Interior said that due to the growing domestic concerns about the mutant virus, it is currently preparing to impose restrictions on the entry of passengers from the United Kingdom, Brazil, and South Africa.
The U.S. and Russia reach an agreement on extending the New Strategic Arms Reduction Treaty
On January 26, US President Biden had a telephone conversation with Russian President Putin for the first time after taking office. The Russian Kremlin stated that the two sides agreed to extend the arms control agreement “New Strategic Arms Reduction Treaty,” and the US White House also said that the two sides will work on extending the treaty.
Russian Satellite News Agency quoted the Kremlin News Service on the 26th as saying that Putin and Biden reached an agreement on extending the “New Strategic Arms Reduction Treaty” during a telephone conversation. The source said: “In the near future, both parties will complete all necessary procedures to ensure that this important international mechanism for mutual restriction of nuclear weapons continues to take effect.”
Reuters reported on the 26th that the White House did not immediately confirm the Kremlin’s statement. However, the White House issued a statement saying that the leaders of the United States and Russia agreed to let their working groups urgently start work on the extension of the New Strategic Arms Reduction Treaty.
The United States and Russia signed the “New Strategic Arms Reduction Treaty” in 2010, which aims to limit the number of strategic nuclear warheads and delivery vehicles deployed by the two countries. After the US-Russia “China-Range Nuclear Forces Treaty” expired in 2019, the “New Strategic Arms Reduction Treaty” became the only arms control treaty between the two countries. The treaty will expire on February 5, 2021, but the validity of the treaty can be negotiated between the two countries It will be extended at most 5 years later. In 2020, the United States and Russia launched several rounds of negotiations on the extension of the treaty. In October of that year, the two sides proposed to extend the treaty for one year but ultimately failed to finalize the details.
U.S. COVID-19 patient dies hours after vaccination
A person infected with the new coronavirus in California, USA, died a few hours after being vaccinated with the new coronavirus on the 21st. The cause of death has not been identified, and it is not clear whether the deceased was vaccinated with Modena or Pfizer.
According to Fox News, the Placer County Sheriff’s Office in California announced on Saturday (23rd) that a resident who tested positive for the new coronavirus in December 2020 will be vaccinated on January 21, 2021. Received the vaccine, but died a few hours later.
The sheriff’s office said that at present, many local, state, and federal agencies are actively investigating the case. It is too early to talk about the cause of death, and the results of the investigation are still pending.
According to the report, it is still unclear whether the vaccine for the deceased was Moderna or Pfizer.
According to previous reports, a report issued by the US Centers for Disease Control and Prevention on the 22nd showed that as of January 10, a total of 4,041,396 people in the United States had received the first dose of the covid vaccine developed by Modena in the United States, and a total of 1,266 cases of adverse effects were reported Reaction events (adverse reaction rate is about 0.03%), including 10 allergic reactions. Previously, the center reported that as of December 23, 2020, a total of 1,893,360 people in the United States had received the first dose of Pfizer’s covid vaccine, and a total of 4,393 adverse events were reported, including 21 allergic reactions.
According to data from Johns Hopkins University, in the past month, an average of 423 people died of new coronavirus every day in California. The state has currently recorded 36,362 deaths.